EMEA-001523-PIP02-14-M03 - paediatric investigation plan
Guselkumab
PIPHuman
Key facts
- Invented name
- Tremfya
- Tremfya
- Active Substance
- Guselkumab
- Therapeutic area
- Immunology-Rheumatology-Transplantation
- Decision number
- P/0346/2023
- PIP number
- EMEA-001523-PIP02-14-M03
- Pharmaceutical form(s)
- Solution for injection
- Condition(s) / indication(s)
- Treatment of psoriasis
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
Janssen Cilag International NV
Tel. +3214602111
E-mail: [email protected]- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date